Cargando…
The Study of a Novel Sorafenib Derivative HLC-080 as an Antitumor Agent
In this study, our objective is to evaluate the potential of a novel Sorafenib derivative, named HLC-080, as a new anticancer agent for colon cancer. We firstly carried out MTT assay, colony formation assay, flow cytometry analysis and transwell invasion assay to determine effect of our compound HLC...
Autores principales: | Tang, Ke, Luo, Can, Li, Yan, Lu, Chenshu, Zhou, Wanqi, Huang, Haihong, Chen, Xiaoguang |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Public Library of Science
2014
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4086976/ https://www.ncbi.nlm.nih.gov/pubmed/25004130 http://dx.doi.org/10.1371/journal.pone.0101889 |
Ejemplares similares
-
HL-HLC Opening the door
por: Hertzog, Samuel Joseph
Publicado: (2019) -
Experiments T23 and T66 in HLC
por: Lagarrigue, A
Publicado: (1964) -
Flavour physics with HL/HE-HLC with ATLAS
por: Reznicek, Pavel
Publicado: (2017) -
The upgrade of the ATLAS Luminosity detector (LUCID) for HL-HLC
por: ATLAS LUCID Collaboration, et al.
Publicado: (2022) -
The upgrade of the ATLAS Luminosity detector (LUCID) for HL-HLC
por: Lasagni Manghi, Federico
Publicado: (2022)